What is the recommended treatment for syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Syphilis

Benzathine penicillin G administered intramuscularly is the definitive treatment for all stages of syphilis, with dosing determined by disease stage. 1, 2

Primary and Secondary Syphilis

Administer benzathine penicillin G 2.4 million units IM as a single dose. 1, 2

  • This regimen achieves 90-100% treatment success rates for early syphilis 3
  • For children with acquired primary or secondary syphilis, dose is 50,000 units/kg IM, up to the adult dose of 2.4 million units 2

Early Latent Syphilis

Give benzathine penicillin G 2.4 million units IM as a single dose. 1, 2

  • Early latent syphilis is defined as infection acquired within the preceding year, documented by seroconversion, fourfold titer increase, history of symptoms, or having a sex partner with documented early syphilis 1

Late Latent Syphilis and Tertiary Syphilis

Administer benzathine penicillin G 7.2 million units total as 3 doses of 2.4 million units IM each at 1-week intervals. 1, 2

  • If a dose is missed, an interval of 10-14 days between doses may be acceptable before restarting the sequence 1
  • This applies to both late latent syphilis (or latent syphilis of unknown duration) and tertiary syphilis 1, 2

Neurosyphilis

Use aqueous crystalline penicillin G for neurosyphilis treatment. 1

  • CSF examination is indicated for patients with neurological signs/symptoms, tertiary syphilis, or those whose serological titers fail to decline appropriately 1
  • Neurosyphilis can occur at any stage and may cause meningitis, uveitis, hearing loss, or stroke 4

Penicillin-Allergic Patients (Non-Pregnant)

For primary and secondary syphilis: doxycycline 100 mg orally twice daily for 14 days. 1, 2

For late latent syphilis: doxycycline 100 mg orally twice daily for 28 days. 1, 2

Critical Caveat for Penicillin Allergy

  • Pregnant women and neurosyphilis patients must receive penicillin regardless of allergy history - they should undergo desensitization followed by penicillin treatment, as penicillin is the only proven effective therapy for preventing maternal transmission and treating neurosyphilis 1, 2, 5
  • Tetracyclines, doxycycline, and erythromycin are contraindicated in pregnancy due to hepatotoxicity, fetal bone/teeth staining, and failure to reliably cure fetal infection 5

Pregnancy-Specific Considerations

For primary, secondary, or early latent syphilis in pregnancy: benzathine penicillin G 2.4 million units IM in a single dose. 5

  • Some specialists recommend a second dose of 2.4 million units IM one week after the initial dose, especially in the third trimester or for women with secondary syphilis or HIV infection 5

For late latent or latent syphilis of unknown duration in pregnancy: benzathine penicillin G 7.2 million units total as 3 doses of 2.4 million units IM each at weekly intervals. 5

  • Up to 40% of fetuses with in-utero syphilis exposure are stillborn or die from infection during infancy if untreated 4
  • All pregnant women should be screened for syphilis at the first prenatal visit, with high-risk populations requiring additional screening at 28-32 weeks gestation and at delivery 5
  • Women should seek immediate obstetric attention if they notice contractions or decreased fetal movements within 24 hours of treatment due to potential Jarisch-Herxheimer reaction 5

HIV-Infected Patients

Use the same treatment regimens as for non-HIV-infected patients. 1, 2

  • HIV-infected patients may have atypical serologic responses but generally respond well to standard treatment 1
  • For pregnant women with HIV, consider a second dose of benzathine penicillin G 2.4 million units IM one week after the initial dose 5

Follow-Up and Monitoring

Repeat quantitative nontreponemal serologic tests (RPR or VDRL) at 3,6,12, and 24 months after treatment. 1

  • A fourfold decline in titer is expected within 6 months for primary/secondary syphilis and within 12-24 months for late syphilis 1, 2
  • Treatment failure is defined as failure of nontreponemal test titers to decline fourfold within 6 months after therapy for primary or secondary syphilis 1, 2
  • If treatment failure is suspected, re-evaluate for HIV infection and perform CSF examination 1
  • For pregnant women, check serologic titers monthly until delivery to ensure adequate treatment response, and repeat titers in the third trimester and at delivery 5

Management of Sexual Partners

Persons exposed within 90 days preceding diagnosis of primary, secondary, or early latent syphilis should be treated presumptively even if seronegative. 1, 2, 5

  • Persons exposed >90 days before diagnosis should be treated presumptively if serologic test results are not immediately available and follow-up is uncertain 1, 2
  • Long-term sex partners of patients with late syphilis should be evaluated clinically and serologically 2, 5

Important Pitfalls to Avoid

  • Do not use oral penicillin preparations - they are ineffective for syphilis treatment 1
  • Do not rely solely on treponemal test antibody titers to assess treatment response, as they correlate poorly with disease activity 1
  • Do not switch between different testing methods (e.g., VDRL and RPR) when monitoring serologic response, as results cannot be directly compared 1
  • Do not delay treatment in pregnancy due to concerns about Jarisch-Herxheimer reaction causing stillbirth - untreated syphilis causes far greater fetal harm 5
  • Do not discharge a newborn without documented maternal syphilis screening 5

Jarisch-Herxheimer Reaction

  • An acute febrile reaction may occur within 24 hours after any syphilis therapy, especially in early syphilis, and may include headache, myalgia, and other symptoms 1
  • Patients should be informed about this possible adverse reaction before treatment 1

References

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Syphilis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: A Review.

JAMA, 2025

Guideline

Syphilis Treatment in Pregnant Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.